448 related articles for article (PubMed ID: 27452409)
41. Improving dose delivery by adding interstitial catheters to fixed geometry applicators in high-dose-rate brachytherapy for cervical cancer.
Otter S; Coates A; Franklin A; Cunningham M; Stewart A
Brachytherapy; 2018; 17(3):580-586. PubMed ID: 29426744
[TBL] [Abstract][Full Text] [Related]
42. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study.
Fokdal L; Sturdza A; Mazeron R; Haie-Meder C; Tan LT; Gillham C; Šegedin B; Jürgenliemk-Schultz I; Kirisits C; Hoskin P; Pötter R; Lindegaard JC; Tanderup K
Radiother Oncol; 2016 Sep; 120(3):434-440. PubMed ID: 27113795
[TBL] [Abstract][Full Text] [Related]
43. Optimal Number of Needle Applicators Inserted in Combined Intracavitary and Interstitial Brachytherapy for Cervical Cancer.
Hirai R; Ohta T; Igari M; Kumazaki YU; Iino M; Aoshika T; Ryuno Y; Saito S; Abe T; Noda SE; Kato S
Anticancer Res; 2023 Jul; 43(7):3265-3271. PubMed ID: 37351988
[TBL] [Abstract][Full Text] [Related]
44. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872
[TBL] [Abstract][Full Text] [Related]
45. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective.
Lindegaard JC; Fokdal LU; Nielsen SK; Juul-Christensen J; Tanderup K
Acta Oncol; 2013 Oct; 52(7):1510-9. PubMed ID: 23962242
[TBL] [Abstract][Full Text] [Related]
46. Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.
Kamran SC; Manuel MM; Cho LP; Damato AL; Schmidt EJ; Tempany C; Cormack RA; Viswanathan AN
Gynecol Oncol; 2017 May; 145(2):284-290. PubMed ID: 28318644
[TBL] [Abstract][Full Text] [Related]
47. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
[TBL] [Abstract][Full Text] [Related]
48. Single line source with and without vaginal loading and the impact on target coverage and organ at risk doses for cervix cancer Stages IB, II, and IIIB: treatment planning simulation in patients treated with MRI-guided adaptive brachytherapy in a multicentre study (EMBRACE).
Nkiwane KS; Pötter R; Tanderup K; Federico M; Lindegaard JC; Kirisits C
Brachytherapy; 2013; 12(4):317-23. PubMed ID: 23474352
[TBL] [Abstract][Full Text] [Related]
49. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
50. Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: Final results of the EMBRACE study dummy run.
Kirisits C; Federico M; Nkiwane K; Fidarova E; Jürgenliemk-Schulz I; de Leeuw A; Lindegaard J; Pötter R; Tanderup K
Radiother Oncol; 2015 Dec; 117(3):548-54. PubMed ID: 26316396
[TBL] [Abstract][Full Text] [Related]
51. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
[TBL] [Abstract][Full Text] [Related]
52. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
[TBL] [Abstract][Full Text] [Related]
53. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
54. Magnetic Resonance Imaging-Guided Adaptive Brachytherapy for the Treatment of Cervical Cancer and its Impact on Clinical Outcome.
Singhal S; Veeratterapillay J; Locks S; Morgan D; Patil R; Chamberlain HM
Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):442-451. PubMed ID: 35123850
[TBL] [Abstract][Full Text] [Related]
55. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
[TBL] [Abstract][Full Text] [Related]
56. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix.
Zwahlen D; Jezioranski J; Chan P; Haider MA; Cho YB; Yeung I; Levin W; Manchul L; Fyles A; Milosevic M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1157-64. PubMed ID: 19101097
[TBL] [Abstract][Full Text] [Related]
57. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy.
Dimopoulos JC; Petrow P; Tanderup K; Petric P; Berger D; Kirisits C; Pedersen EM; van Limbergen E; Haie-Meder C; Pötter R
Radiother Oncol; 2012 Apr; 103(1):113-22. PubMed ID: 22296748
[TBL] [Abstract][Full Text] [Related]
58. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study.
Knoth J; Pötter R; Jürgenliemk-Schulz IM; Haie-Meder C; Fokdal L; Sturdza A; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Wiebe E; Rai B; Cooper R; van der Steen-Banasik E; van Limbergen E; Pieters BR; Sundset M; Tan LT; Nout RA; Tanderup K; Kirisits C; Nesvacil N; Lindegaard JC; Schmid MP
Gynecol Oncol; 2020 Oct; 159(1):136-141. PubMed ID: 32798000
[TBL] [Abstract][Full Text] [Related]
59. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
[TBL] [Abstract][Full Text] [Related]
60. Education and training for image-guided adaptive brachytherapy for cervix cancer-The (GEC)-ESTRO/EMBRACE perspective.
Tan LT; Tanderup K; Kirisits C; Mahantshetty U; Swamidas J; Jürgenliemk-Schulz I; Lindegaard J; de Leeuw A; Nesvacil N; Assenholt M; Berger D; Diendorfer T; Dimopoulos J; Duke S; Ecker S; Fokdal L; Hellebust T; Jensen N; Kirchheiner K; Nout R; Petric P; Schmid M; Seppenwoolde Y; Sturdza A; Van Limbergen E; Haie-Meder C; Pötter R
Brachytherapy; 2020; 19(6):827-836. PubMed ID: 32811761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
